Olympian Gabby Thomas Draws Crowd at Wellness Event with BetterWay(TM) Blood Testing at H-E-B SoCo
Guests had an opportunity to meet Gabby Thomas, win health-focused prizes, and learn simple ways to take a more active...
Day: January 10, 2026
Best Weight Loss Pills for 2026: FDA Approves First Oral GLP-1 and What It Means for Patients
NEW YORK CITY, NY / ACCESS Newswire / January 10, 2026 / The phrase best weight loss pills for 2026...
UOG (United One Group) Wins Three Prestigious Industry Awards at CES 2026
CES Official Spokesperson Highlights UOG Featured ProductsIntroducing the World's First Black Diamond Carbon & Nano Silver Fusion Wellness TechnologyLAS VEGAS,...
Best Ipamorelin vs Sermorelin: Growth Hormone Peptide Comparison 2026 — ReadyRx Prescription Telehealth Analysis
Independent research summary reviews mechanisms, regulatory considerations, and telehealth access pathways as consumers compare growth hormone secretagogues heading into 2026.CHEYENNE,...
GLP-1 Booster From Health Journey: 2026 Ingredient Analysis And Probiotic Metabolic Support Explained
Examining Akkermansia Muciniphila, Clostridium Butyricum, And The Gut Microbiome Research Behind This Probiotic GLP-1 Supplement — What The Science Shows...
MEDVi GLP-1 Investigation: What Consumer Data Shows About Compounded Telehealth Weight Loss Programs
Independent Analysis Examines MEDVi's Semaglutide Medication Model, FDA Compounding Framework, and Prescription Accessibility Trends Heading Into 2026NEWARK, DE, Jan. 09,...
Best Peptides for Anti-Aging: NAD+ Delivery Methods Compared as Telehealth Platforms Expand Access (2026 Analysis)
Published NAD+ research examines cellular aging pathways and mitochondrial function as prescription peptide injection access expands through telehealth — here...
Foghorn Therapeutics Highlights January Equity Financing, Program Progress and Strategic Objectives for 2026
Recently raised $50 million with BVF Partners, Deerfield Management, founding investor Flagship Pioneering and a leading biotech mutual fund in...
Anti-Snoring Mouthpiece vs Nose Strips: Consumer Analysis Explains Why Product Format May Matter More Than Brand
How Jaw-Positioning Devices and Nasal Products Differ — SleepZee Examined Within Mouthpiece Category ContextChicago, IL, Jan. 09, 2026 (GLOBE NEWSWIRE)...
Best Collagen Patch 2026: Consumer Analysis of Transdermal vs Oral vs Topical Delivery
Independent Report Examines Collagen Patch Benefits, Delivery Science, and What Consumers Evaluate — With Invig+ as Category ReferenceNEW YORK, NY,...
Best Berberine Patch for Transdermal Metabolic Support: NuraPatch Cited in Industry Analysis as Consumer Interest in Botanical Weight Management Options Grows
Examination of transdermal berberine delivery, GLP-1 pathway terminology in supplement marketing, and consumer evaluation criteria as searches for non-prescription metabolic...
Best Peptides for Skin Care: Injectable vs Topical Delivery Methods – RenuviaRX Consumer Analysis
January 2026 Wellness Season: Glutathione Tripeptide Therapy, Cellular Skin Support Mechanisms, and Telehealth Access Pathways for Injectable Peptide OptionsSHERIDAN, WY,...
Etienna Bio Secures Exclusive Worldwide License from UMass Chan Medical School for Novel Adipose-Derived Regenerative Platform
LEAWOOD, Kan., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Etienna Bio, Inc., a biotechnology company focused on next-generation autologous and cell-enabled...
Ascendis Pharma Provides Business and Strategic Roadmap Update at 44th Annual J.P. Morgan Healthcare Conference
- Rapidly transforming into a leading global biopharma companyCOPENHAGEN, Denmark, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:...
Cooper Aerobics Partners with The Stayton at Museum Way
Wellness Center Management & Wellness Programming by CooperDALLAS and FORT WORTH, Texas, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Cooper Wellness...
U.S. Neurology Associates Partners with M33 Growth to Transform Neurological Care
DALLAS and BOSTON, Jan. 09, 2026 (GLOBE NEWSWIRE) -- M33 Growth, a Boston-based venture and growth-stage investment firm, today announced...